Featured in the prestigious scientific journal, Cancer Cell, one of our labs contains the Childhood Cancer Model Atlas (CCMA), the world’s largest collection of high-risk #Paediatric #Cancer cell lines, providing a unique, open-source facility to cancer researchers worldwide. 🌏

Our researchers discuss The #Childhood #Cancer Model Atlas (CCMA), the world’s largest collection of high-risk paediatric cancer cell lines. 🧬 To find out more, follow the link here: bit.ly/3M2iezG CCF @VPCCresearch RCD Foundation

Looking forward to presenting at this ASMR workshop alongside Anna! It is always a privilege to hear Anna talk about her experience living with a rare and incurable blood cancer, as well as the amazing advocacy and consumer work she does. Don't miss out!

Huge thank you to Tour De Cure for supporting our research, allowing us to explore a new leukaemia modelling approach in the lab!

Great to see this fantastic work published! Thrilled to have been involved with this study. Thanks Scott_lab_GMP et al., for the collaboration.

Great news for peanut allergic babies!!! My 9 year old (formerly allergic) son is able to eat peanuts regularly now - thanks to a clinical trial run by MCRI when he was 2. Forever grateful we had the opportunity to be involved in that trial 🥜 💪

I had the privilege of meeting two remarkable teens, Tianna and Raya, who fought and beat leukaemia during covid lockdowns. Now they want futures in the medical world to help other kids. Their story on ABC News Breakfast

Thanks ABC news & Stephanie Ferrier for sharing Tianna & Raya's story. It was lovely having Tianna and Raya in the lab Hudson Institute of Medical Research. We learnt so much from them about their leukemia journey and the need to improve outcomes for kids with leukaemia. abc.net.au/news/2024-11-2…

The Scientific and Organising Committees would like to invite you to be a part of the New Directions in Leukaemia Research (NDLR) Meeting 2026 being held in Adelaide, Australia Mon 2 March - Wed 4 March 2026.

We are happy to announce some key dates for NDLR 2026. Hope to see you there!

We are please to announce that Dr Lindsey Montefiori will be joining us as an invited speaker for NDLR 2026. #NDLR2026

A huge thank you to Leukaemia Foundation for sponsoring NDLR 2026!

We are honoured to welcome Professor John D. Crispino, from St. Jude as speaker to #NDLR2026. John’s research focuses on mechanisms of #Leukemia development in children with Down syndrome and the malignant progression of #MyelodysplasticSyndrome and #MyeloproliferativeNeoplasms.

Exciting News! Prof. Jan Cools, KU Leuven, Editor-in-Chief of HemaSphere Journal (IF = 14.6), is speaking at #NDLR2026. Jan researches #TumorHeterogeneity, transcription factor deregulation and constitutive kinase signaling of acute lymphoblastic #leukemia using #Omics.

🚨 Call for Abstracts Now Open #NDLR2026 🚨 Only 3 weeks left to submit your abstracts! 🗓 Submission closes 23/09/2025 🩸 Submit now: ndlr.org.au 🎟️ Earlybird Registration is now open – secure your spot today! #BloodCancer #CancerResearch #ChildhoodCancer

We are thrilled to announce that Associate Professor Julia Maxson from OHSU Knight Cancer Institute Cancer Institute, USA, will be joining us at #NDLR2026. Julia's research focuses on investigating the cellular and molecular changes that cause myeloid #Leukemia.

We are honoured to welcome clinician-scientist Prof Steve Lane from QIMR Berghofer as a speaker to #NDLR2026. Steven’s research concentrates on understanding how #leukemia stem cells in #AcuteMyeloidLeukemia and #MyeloproliferativeNeoplasm can regenerate leukemia.

We are thrilled to introduce our new #NDLR2026 Meet-the-Editor session, with esteemed Editors-in-Chief, Prof. Andrew Roberts Roberts from Blood and Prof. Jan Cools, HemaSphere Journal (IF = 14.6) who will share their invaluable insights on publishing in high-impact hematology journals.

🚨 Call for Abstracts Now Open #NDLR2026 🚨 Only 1 week left to submit your abstracts! 🗓 Abstract submission closes 23 September 2025 🩸 Submit now: ndlr.org.au